Menopause Hormone Therapy (HRT) in Columbia, MO

Bioidentical hormones in Columbia: what it means

"Bioidentical" describes a hormone whose chemical structure matches one the body makes. Two hormones used in menopause care fit it exactly, estradiol and micronized progesterone. Both come in FDA-approved prescription forms, from estradiol pills, patches, gels and vaginal forms to progesterone capsules.

"BHRT" often means compounded hormones, a cream, a blend such as Bi-Est or a pellet that a pharmacy mixes for one prescription. They are not FDA-approved, which means the FDA cannot assure their safety or effectiveness. The FDA also says it has no evidence that they are safe and effective, or more effective than approved hormone therapy. A 2020 National Academies review found no rigorous evidence of their safety and effectiveness.

For women in Columbia, a physician licensed in Missouri can prescribe estradiol (pill, patch, cream or vaginal) and progesterone when they fit your history. There are no pellets. Because the dispensing pharmacy also compounds, you can ask whether your estradiol or progesterone is an FDA-approved product. Two options are compounded for certain: testosterone cream for women and Bi-Est are not FDA-approved.

The NPI registry counts 93 OB-GYNs practicing in Columbia, about 73.1 for every 100,000 residents against 17.8 nationally and above Missouri's 18.5, a higher rate than 93% of the cities VevaMD covers. Set against the city's 11,638 women aged 45 to 64, that is one OB-GYN for roughly every 130.

Beyond the city line the count barely changes: 93 OB-GYNs within 10 miles and 93 within 25, for the 241,335 people who live in that radius (38.5 per 100,000). VevaMD is an online option alongside them: a physician licensed in Missouri reviews your intake from Columbia without an office visit, and an OB-GYN you already see stays your doctor.

Then there are pellets, implanted under the skin at a clinic; compounded pellets are not FDA-approved. The Endocrine Society points to a study that found hormone levels well above the expected range in women using them. ACOG advises FDA-approved hormone therapy over compounded preparations.

Sources: FDA: Menopause · FDA: National Academies study of compounded bioidentical hormones (2020) · Endocrine Society position statement on compounded bioidentical hormones (2019) · ACOG Clinical Consensus No. 6, compounded bioidentical menopausal hormone therapy (2023) · CMS NPPES NPI full file, 2026-10-11